Literature DB >> 508559

Plasma rifampicin assay by an improved solvent extraction technique.

J B McConnell, H Smith, M Davis, R Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 508559      PMCID： PMC1429818          DOI： 10.1111/j.1365-2125.1979.tb01035.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Metabolic study and controlled clinical trials of rifampin.

Authors:  S Sunahara; H Nakagawa
Journal:  Chest       Date:  1972-06       Impact factor: 9.410

2.  Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.

Authors:  S Furesz; R Scotti; R Pallanza; E Mapelli
Journal:  Arzneimittelforschung       Date:  1967-05

3.  Quantitative assay of rifampicin and three of its metabolites in human plasma, urine and saliva by high-performance liquid chromatography.

Authors:  J B Lecaillon; N Febvre; J P Metayer; C Souppart
Journal:  J Chromatogr       Date:  1978-03-01

4.  Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.

Authors:  G Acocella; L Bonollo; M Garimoldi; M Mainardi; L T Tenconi; F B Nicolis
Journal:  Gut       Date:  1972-01       Impact factor: 23.059
  4 in total
  3 in total

1.  Porphyrin metabolism and haem biosynthesis in Gilbert's syndrome.

Authors:  K E McColl; G G Thompson; E el Omar; M R Moore; A Goldberg
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

2.  Effect of rifampicin on haem and bilirubin metabolism in man.

Authors:  K E McColl; G G Thompson; E el Omar; M R Moore; B K Park; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

3.  Comparative bioavailability and in-vitro antimicrobial activity of two different brands of rifampicin.

Authors:  S K Garg; A Chakrabarti; D Panigrahi; M Sharma; P Talwar; N Kumar; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.